ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

Cancer death rate dropping 1.1 percent a year, annual report finds.

October 7, 2005

CAP, ASCCP Recommendations Standardize Lesion Terminology

July 27, 2012

NIH Programs: Mouse Is next In Line For DNA Sequencing

October 29, 1999

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007

In Brief: One More Committee Review Needed for L.A., Rhode Island; Animal Tests In Factories (?)

May 13, 1977

New Genetic Test Approved For Breast Cancer Patients

July 25, 2008